Myriad Genetics (MYGN) PT Raised to $27 at BofA Securities

August 4, 2021 5:30 AM EDT Send to a Friend
BofA Securities analyst Derik de ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login